Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MREC-based therapeutic optimization in Crohn's disease
NCT02332356Phase 3Unknown
- Sponsor
- Tokyo Medical and Dental University
- Start
- Sep 2014
- Primary completion
- Mar 2024
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of azathioprine, adalimumab, infliximab in Crohn's disease, sponsored by Tokyo Medical and Dental University. Status: unknown.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02332356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332356.